These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9229416)

  • 1. Esophageal cancer surgery: the value of controlled clinical trials.
    Law SY; Wong J
    Semin Surg Oncol; 1997; 13(4):281-7. PubMed ID: 9229416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY; Ilson DH
    Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
    Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
    BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
    Moaven O; Wang TN
    Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative therapy.
    Homs MY; Kuipers EJ; Siersema PD
    J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for esophageal cancer.
    Heath EI; Forastiere AA
    Cancer Treat Res; 2001; 105():387-98. PubMed ID: 11224996
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant therapy of esophageal carcinoma.
    Reed CE
    Chest Surg Clin N Am; 1994 May; 4(2):299-314. PubMed ID: 8049998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on Randomized Clinical Trials in Gastric Cancer.
    Tseng J; Posner MC
    Surg Oncol Clin N Am; 2017 Oct; 26(4):621-645. PubMed ID: 28923222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the treatment of esophageal cancer.
    Ilson DH
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemoradiotherapy for advanced esophageal cancer].
    Natsugoe S; Matsumoto M; Okumura H; Uchikado Y; Setoyama T; Kita Y; Arigami T; Uenosono Y; Owaki T; Ishigami S
    Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):111-6. PubMed ID: 21488344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy of esophageal cancer: an update.
    Kelsen DP
    Cancer J; 2000 Apr; 6 Suppl 2():S177-81. PubMed ID: 10803833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal and esophagogastric junction cancers.
    Ajani JA; Barthel JS; Bentrem DJ; D'Amico TA; Das P; Denlinger CS; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD;
    J Natl Compr Canc Netw; 2011 Aug; 9(8):830-87. PubMed ID: 21900218
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
    Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment of cancer arising from Barrett's epithelium.
    Roth JA
    World J Surg; 1995; 19(2):205-9. PubMed ID: 7754624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of carcinoma of the esophagus.
    Seibert DG; Hill RC
    W V Med J; 1989 Feb; 85(2):53-7. PubMed ID: 2464245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.
    Franco P; Arcadipane F; Strignano P; Spadi R; Trino E; Martini S; Iorio GC; Satolli MA; Airoldi M; Romagnoli R; Camandona M; Ricardi U
    Med Oncol; 2017 Mar; 34(3):40. PubMed ID: 28176241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophagogastric junction adenocarcinoma: which therapeutic approach?
    Mariette C; Piessen G; Briez N; Gronnier C; Triboulet JP
    Lancet Oncol; 2011 Mar; 12(3):296-305. PubMed ID: 21109491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of multimodality therapy for esophageal carcinoma.
    Tak VM; Naunheim KS
    J Surg Res; 2004 Mar; 117(1):22-9. PubMed ID: 15013710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.